Editorial

Cancer, Bad Luck and Press Releases…
January 26, 2015

Everything started with a headline: “Most cancers are caused by bad luck – not bad judgement, says study” (Independent), and another:…

Read More
2014 in Numbers
January 19, 2015

As is our tradition, here you have our figures about projects and products of 2014. Compiling this info takes only a…

Read More
Are cars becoming more innovative than drugs?
December 12, 2014

For the first time in 10 years there is no pharmaceutical company among the three biggest R&D spenders! According to the…

Read More
Lorcaserin approved
June 29, 2012

Well, it is the first anti-obesity drug approved by the FDA in 13 years (last one was Roche’s Orlistat, marketed as Xenical…

Read More
GalChimiApplus
December 1, 2011

During the last CPhI in Frankfurt we officially presented our joint venture with Applus+ LGAI, christening it GalChimiApplus. This collaboration will…

Read More
Number crunching
October 1, 2011

The review selected for this issue is in fact what the J. Med. Chem. calls a ‘Perspective’ paper. To summarize, it…

Read More
Challenging Chemistry
October 1, 2011

Are medicinal chemists simple-minded? Have they forgotten how to synthesize molecules? Have they become lazy? If you think the answers to…

Read More
Apologies and changes
September 1, 2011

Well, it has been a long, long time. Issue 18 of the newsletter was published on April 1st, so you readers…

Read More
The End of the World
September 1, 2011

IT’S THE END OF THE WORLD AS WE KNOW IT Probably most of you are not familiar with this song by…

Read More
Glasnost
November 1, 2010

Last Year Figures If you have lived through the 80s you will probably remember this word. Another year is behind us…

Read More